News

Cyclacel Pharmaceuticals Enhances Collaborative Agreement with FITTERS

Cyclacel Pharmaceuticals Enhances Collaborative Agreement with FITTERS

Cyclacel Pharmaceuticals Strengthens Its Partnership with FITTERS

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) has made a significant move to enhance its operational framework by amending its Exchange Agreement with FITTERS Diversified Berhad. This amendment signifies a strategic collaboration aimed at leveraging each company's strengths and expanding their market reach.

Details of the Exchange Agreement Amendment

Under the revised terms of the Exchange Agreement, all ordinary shares of FITTERS’ subsidiary, Fitters Sdn. Bhd., will be exchanged for common stock of Cyclacel, referred to as Purchaser Stock. Following this transaction, Fitters Sdn. Bhd. will become a wholly-owned subsidiary of Cyclacel. This transaction will include the issuance of Purchaser Stock that constitutes approximately 19.99% of the total issued shares as of the closing date.

Financial Considerations and Timeframe

As part of this transaction, Cyclacel will also provide a monetary consideration of USD $1,000,000 to FITTERS or another mutually agreed amount upon closing. The closing date has been extended, allowing all necessary approvals to be secured by September 30, 2025.

The Approval Process

For the Transaction to progress effectively, it must receive approval from stockholders of both Cyclacel and FITTERS. Notably, the boards of directors from both companies have shown unanimous support for this agreement.

About Fitters Sdn. Bhd.

Fitters Sdn. Bhd. is known for its expertise in fire safety materials and systems. With a strong reputation for reliability, they provide fire retardant uniforms, personal protective equipment, and various fire safety products ranging from extinguishers to fire-resistant doors. Their commitment to safety and quality serves a broad spectrum of sectors including commercial, industrial, healthcare, and residential needs.

Fitters' Mission and Offerings

The mission of Fitters is to deliver high-quality, certified safety solutions, ensuring compliance with regulatory standards. Their innovative approach has positioned them as a one-stop specialist in protective clothing and fire safety supplies, meeting diverse client demands.

About Cyclacel Pharmaceuticals, Inc.

Cyclacel is at the forefront of developing innovative cancer therapies that focus on cell cycle regulation, epigenetics, and mitosis biology. Among their active projects is the evaluation of plogosertib, a potent PLK1 inhibitor aimed at treating both solid tumors and hematological malignancies. The company concentrates on building a diverse pipeline of unique drug candidates targeting oncology and hematology.

Looking Ahead

This recent amendment reflects Cyclacel's commitment to enhancing its operational frameworks and diversifying its portfolio. By collaborating with FITTERS, Cyclacel is poised to harness new efficiencies and drive growth in the biopharmaceutical sector, ensuring that both companies benefit from shared resources and strategic synergies.

Frequently Asked Questions

What is the purpose of the amended Exchange Agreement between Cyclacel and FITTERS?

The amendment aims to strengthen the partnership by exchanging shares and establishing Fitters Sdn. Bhd. as a wholly-owned subsidiary of Cyclacel.

What percentage of Cyclacel's stock will FITTERS receive?

FITTERS will receive stock amounting to 19.99% of the total issued shares of Cyclacel as part of the transaction.

When is the expected closing date for the transaction?

The closing date has been extended to September 30, 2025, to allow time for necessary approvals.

What types of products does Fitters Sdn. Bhd. specialize in?

Fitters Sdn. Bhd. specializes in fire safety materials, including protective clothing, fire extinguishers, fire-resistant doors, and personal protective equipment.

What role does Cyclacel Pharmaceuticals play in cancer treatment?

Cyclacel focuses on developing innovative cancer therapies that target cell cycle regulation and mitosis biology to treat various forms of cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Global-E Faces Fresh Scrutiny After Muted Quarterly Outlook

Updated Category News Views 28

A guidance bump that barely clears the curb can still wreck a stock. That is the unpleasant read-through from Global-E Online's third-quarter 2026 report: revenue guidance went higher, but not high enough to persuade investors that the business was pulling away from expectations. Shares fell after the release, and a securities-law investigation announced November 19 has...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 57

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Jeff Stern Turns Travel Photography Into a Sensory Memoir

Updated Category News Views 68

Frost in a mountain tent, fermented mare’s milk in a yurt, and coffee in Vietnamese rice paddies are doing more work here than a thousand polished sunset captions ever could. Jeff Stern’s A Change of Scenery, released by Palmetto Publishing on November 17, 2026, comes from a man who spent more than 25 years building brands and then decided the usual labels around...

Continue Reading
Wenge AI Removes a Small Friction Point for ScienceOra

Updated Category News Views 77

Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...

Continue Reading
Scientific Games Takes Big Buck Hunter to Lotteries

Updated Category News Views 84

A mounted arcade cabinet is an odd place to find lottery growth, yet Scientific Games may be onto something with its exclusive Big Buck Hunter licensing deal. Announced November 19, 2026, the arrangement lets the company carry a 26-year-old arcade franchise into U.S. and Canadian instant scratch games, Fast Play, draw games, digital products and second-chance promotions....

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 50

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 87

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 133

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 89

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading
Thanksgiving Kitchen Safety Is No Place for Autopilot

Updated Category News Views 107

Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from BioRestorative's CEO on Regenerative Medicine

Updated Category News Views 168

CEO Lance Alstodt Discusses BioRestorative's Vision In a recent interview on “The Big Biz Show,” the dynamic CEO of BioRestorative Therapies, Inc., Lance Alstodt, shared invaluable insights into the company's journey. As a pioneer in regenerative medicine, BioRestorative focuses on innovative stem cell-based therapies aimed at addressing various medical challenges....

Continue Reading
Hargreave Hale AIM VCT PLC NAV Announcement

Updated Category News Views 73

Hargreave Hale AIM VCT PLC (the “Company”) Net Asset Value Announcement As of the close of business on 16 August 2024, the unaudited Net Asset Value (NAV) for Hargreave Hale AIM VCT plc stands at: NAV per Ordinary share of 1p – 42.03 pence. Contact Information If you need more information, please reach out to: JTC (UK) Limited Uloma Adighibe Alexandria Tivey Email...

Continue Reading
Discover Luxury Living at Toll Brothers' New Community in Texas

Updated Category News Views 150

Introducing Toll Brothers at George's Ranch In a splendid showcase of luxury living, Toll Brothers, Inc. (NYSE:TOL) has unveiled its newest community, Toll Brothers at George's Ranch, located in the serene surroundings of Boerne, Texas. This exciting development marks an important addition to the San Antonio area, where elegance meets modern design. Grand Opening...

Continue Reading
xLean's TR1 Robot Revolutionizes Cleaning Technology

Updated Category News Views 224

xLean's Innovative TR1 Takes Center Stage xLean Robotics concluded an exciting showcase at IFA 2025, where its groundbreaking TR1, the world's first dual-form transformable floor washing robot, earned several prestigious awards. This innovative device was recognized as the 'Best in IFA Next Winner' and 'Best in Design Honoree,' and it was featured as one of the 'Top 5...

Continue Reading
Alpha Modus Sues H&M for Patent Infringement Regarding AI Tech

Updated Category News Views 165

Alpha Modus Files Patent Infringement Lawsuit Against H&M Alpha Modus, Corp. is making headlines for filing a substantial patent infringement lawsuit against H&M Fashion USA, Inc. in the United States District Court for the Eastern District of Texas, Marshall Division. This legal action centers around allegations that H&M's retail operations in the U.S. are infringing...

Continue Reading